MPAC-study: A feasibility study of the co-registration of MRI-imaging with PAthological assessment of primary tumor extension in patients with uterine Cervical tumors.

MPAC-study: MRI and PA correlation in uterine Cervical cancer.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON27815

Enrollment

Registered

2013-03-07

Start date

2013-03-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Validation of MRI for measuring uterine involvement of uterine cervical cancer

Interventions

Measure uterine extension of uterine cervical cancer on MRI and compare with histopathology.

Eligibility

Inclusion criteria

Inclusion criteria: All patients with early uterine cervical cancer (FIGO stages < IIA) for whom a Wertheim Okabayashi procedure and a MRI is planned.

Exclusion criteria

Exclusion criteria: 1. MRI: claustrophobia, pacemaker, medicine pump, neurostimulator, cochlear implants, other metal implants in the pelvis that would disturb the image. In some cases surgical clips in the brain are contra-indicated, this will be evaluated conform standard protocol; 2. GFR < 30 ml/min/1,73 m².

Design outcomes

Primary

Measure	Time frame
Accuracy of linear extension.	—

Secondary

Measure	Time frame
Acccuracy of tumor volume.	—

Contacts

Public ContactPeter Boer, de

Meibergdreef 9 Postbus 22660

p.deboer@amc.nl+31 (0)20 5663433

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)